Atlas Trials

Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma

Clinical trial NCT04124198 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04124198
Sponsor
Christian von Buchwald
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Oropharynx CancerOropharynx Squamous Cell CarcinomaCarcinoma, Squamous CellCarcinomaOropharyngeal NeoplasmsNeoplasms, Squamous CellNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypePharyngeal Neoplasms Malignant and UnspecifiedOtorhinolaryngologic NeoplasmsHead and Neck NeoplasmsNeoplasms by Site
Start date
2019-03-01
Primary completion
2025-12-16
Enrollment
138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.